Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Higher is not automatically better
Mounjaro (tirzepatide) is a novel glucose-lowering medication licensed in the UK for the treatment of type 2 diabetes mellitus in adults
This summer, Truveta Research published its comparative effectiveness study exploring weight loss among patients taking semaglutide (Ozempic) and tirzepatide (Mounjaro) has been published in JAMA Internal Medicine
The American Diabetes Association recommends metformin as the preferred pharmacological option for prediabetes in high-risk individuals
US$ 25.23
US$ 21.28
US$ 28.36
US$ 22.70
US$ 22.33
US$ 26.50
US$ 20.98
